Cavalier Investments LLC raised its stake in CME Group Inc (NASDAQ:CME) by 69.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 4,900 shares of the financial services provider’s stock after buying an additional 2,000 shares during the period. Cavalier Investments LLC’s holdings in CME Group were worth $806,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in CME. Dubuque Bank & Trust Co. boosted its position in CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after buying an additional 69 shares during the period. Resources Investment Advisors Inc. raised its holdings in shares of CME Group by 2,800.0% in the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares in the last quarter. Ruggie Capital Group bought a new stake in shares of CME Group in the 4th quarter valued at about $28,000. Smith Asset Management Group LP raised its holdings in shares of CME Group by 200.0% in the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 100 shares in the last quarter. Finally, Truvestments Capital LLC bought a new stake in shares of CME Group in the 1st quarter valued at about $32,000. 84.98% of the stock is owned by institutional investors.
Several equities research analysts have recently commented on the stock. Citigroup set a $205.00 price target on shares of CME Group and gave the company a “buy” rating in a report on Friday, February 15th. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Thursday, January 31st. JPMorgan Chase & Co. assumed coverage on shares of CME Group in a report on Friday, February 15th. They issued an “underweight” rating and a $164.00 price target for the company. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a report on Wednesday, April 17th. Finally, ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 20th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $189.71.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, topping the consensus estimate of $1.60 by $0.02. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. CME Group’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.86 EPS. Research analysts forecast that CME Group Inc will post 6.62 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be paid a dividend of $0.75 per share. The ex-dividend date is Friday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.67%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
In other news, Director Jeffrey M. Bernacchi sold 10,087 shares of the company’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the sale, the director now directly owns 42,004 shares of the company’s stock, valued at approximately $7,474,191.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Kathleen M. Cronin sold 8,340 shares of the company’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the completion of the sale, the insider now directly owns 41,604 shares in the company, valued at $6,970,334.16. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,489 shares of company stock valued at $6,739,196. 1.20% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/10/cavalier-investments-llc-grows-holdings-in-cme-group-inc-cme.html.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: What is a short straddle?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.